nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—TNF—breast cancer	0.157	0.423	CbGaD
Pomalidomide—CYP3A4—breast cancer	0.0761	0.205	CbGaD
Pomalidomide—PTGS2—breast cancer	0.0745	0.201	CbGaD
Pomalidomide—ABCB1—breast cancer	0.0633	0.171	CbGaD
Pomalidomide—CYP1A2—Anastrozole—breast cancer	0.0298	0.0886	CbGbCtD
Pomalidomide—CYP1A2—Toremifene—breast cancer	0.0273	0.081	CbGbCtD
Pomalidomide—ABCB1—Toremifene—breast cancer	0.0239	0.0709	CbGbCtD
Pomalidomide—CYP3A4—Exemestane—breast cancer	0.0206	0.0613	CbGbCtD
Pomalidomide—CYP3A4—Letrozole—breast cancer	0.0175	0.0521	CbGbCtD
Pomalidomide—ABCB1—Lapatinib—breast cancer	0.0174	0.0517	CbGbCtD
Pomalidomide—CYP3A4—Anastrozole—breast cancer	0.0156	0.0464	CbGbCtD
Pomalidomide—CYP3A4—Toremifene—breast cancer	0.0143	0.0425	CbGbCtD
Pomalidomide—CYP3A4—Fulvestrant—breast cancer	0.0133	0.0395	CbGbCtD
Pomalidomide—CYP3A4—Thiotepa—breast cancer	0.0118	0.0352	CbGbCtD
Pomalidomide—CYP3A4—Ixabepilone—breast cancer	0.0108	0.0322	CbGbCtD
Pomalidomide—CYP3A4—Lapatinib—breast cancer	0.0104	0.031	CbGbCtD
Pomalidomide—CYP1A2—Tamoxifen—breast cancer	0.00996	0.0296	CbGbCtD
Pomalidomide—ABCB1—Vinorelbine—breast cancer	0.00965	0.0287	CbGbCtD
Pomalidomide—ABCB1—Tamoxifen—breast cancer	0.00871	0.0259	CbGbCtD
Pomalidomide—ABCB1—Mitoxantrone—breast cancer	0.0085	0.0252	CbGbCtD
Pomalidomide—CYP3A4—Raloxifene—breast cancer	0.0079	0.0235	CbGbCtD
Pomalidomide—ABCB1—Gemcitabine—breast cancer	0.00751	0.0223	CbGbCtD
Pomalidomide—CYP1A2—Fluorouracil—breast cancer	0.00734	0.0218	CbGbCtD
Pomalidomide—ABCB1—Paclitaxel—breast cancer	0.00678	0.0201	CbGbCtD
Pomalidomide—ABCB1—Irinotecan—breast cancer	0.00669	0.0199	CbGbCtD
Pomalidomide—ABCB1—Vinblastine—breast cancer	0.00595	0.0177	CbGbCtD
Pomalidomide—CYP3A4—Vinorelbine—breast cancer	0.00578	0.0172	CbGbCtD
Pomalidomide—CYP3A4—Tamoxifen—breast cancer	0.00522	0.0155	CbGbCtD
Pomalidomide—CYP3A4—Mitoxantrone—breast cancer	0.00509	0.0151	CbGbCtD
Pomalidomide—ABCB1—Docetaxel—breast cancer	0.0049	0.0146	CbGbCtD
Pomalidomide—CYP3A4—Paclitaxel—breast cancer	0.00406	0.0121	CbGbCtD
Pomalidomide—CYP3A4—Irinotecan—breast cancer	0.00401	0.0119	CbGbCtD
Pomalidomide—ABCB1—Doxorubicin—breast cancer	0.00365	0.0109	CbGbCtD
Pomalidomide—CYP3A4—Vinblastine—breast cancer	0.00356	0.0106	CbGbCtD
Pomalidomide—ABCB1—Methotrexate—breast cancer	0.00354	0.0105	CbGbCtD
Pomalidomide—CYP3A4—Docetaxel—breast cancer	0.00294	0.00873	CbGbCtD
Pomalidomide—Lenalidomide—CDH5—breast cancer	0.00286	0.474	CrCbGaD
Pomalidomide—CYP3A4—Doxorubicin—breast cancer	0.00219	0.00651	CbGbCtD
Pomalidomide—CRBN—nipple—breast cancer	0.00181	0.091	CbGeAlD
Pomalidomide—Lenalidomide—TNFSF11—breast cancer	0.00164	0.272	CrCbGaD
Pomalidomide—CRBN—embryo—breast cancer	0.00149	0.075	CbGeAlD
Pomalidomide—TNF—lymph node—breast cancer	0.00111	0.0557	CbGeAlD
Pomalidomide—CRBN—endometrium—breast cancer	0.00109	0.0549	CbGeAlD
Pomalidomide—CRBN—uterus—breast cancer	0.00101	0.0506	CbGeAlD
Pomalidomide—CRBN—pituitary gland—breast cancer	0.000987	0.0497	CbGeAlD
Pomalidomide—CRBN—adipose tissue—breast cancer	0.000983	0.0495	CbGeAlD
Pomalidomide—CRBN—female reproductive system—breast cancer	0.000904	0.0455	CbGeAlD
Pomalidomide—CRBN—adrenal gland—breast cancer	0.000882	0.0444	CbGeAlD
Pomalidomide—CRBN—bone marrow—breast cancer	0.000853	0.0429	CbGeAlD
Pomalidomide—CRBN—female gonad—breast cancer	0.000822	0.0414	CbGeAlD
Pomalidomide—CRBN—endocrine gland—breast cancer	0.000765	0.0385	CbGeAlD
Pomalidomide—Thalidomide—FGFR2—breast cancer	0.000623	0.103	CrCbGaD
Pomalidomide—CYP1A2—nipple—breast cancer	0.000594	0.0299	CbGeAlD
Pomalidomide—CRBN—lymph node—breast cancer	0.000529	0.0266	CbGeAlD
Pomalidomide—PTGS2—embryo—breast cancer	0.000406	0.0204	CbGeAlD
Pomalidomide—PTGS2—epithelium—breast cancer	0.000331	0.0167	CbGeAlD
Pomalidomide—PTGS2—skin of body—breast cancer	0.000315	0.0159	CbGeAlD
Pomalidomide—PTGS2—endometrium—breast cancer	0.000297	0.015	CbGeAlD
Pomalidomide—PTGS2—uterus—breast cancer	0.000274	0.0138	CbGeAlD
Pomalidomide—PTGS2—pituitary gland—breast cancer	0.000269	0.0135	CbGeAlD
Pomalidomide—PTGS2—adipose tissue—breast cancer	0.000268	0.0135	CbGeAlD
Pomalidomide—CYP1A2—endocrine gland—breast cancer	0.000251	0.0127	CbGeAlD
Pomalidomide—ABCB1—embryo—breast cancer	0.000251	0.0126	CbGeAlD
Pomalidomide—PTGS2—female reproductive system—breast cancer	0.000246	0.0124	CbGeAlD
Pomalidomide—PTGS2—adrenal gland—breast cancer	0.00024	0.0121	CbGeAlD
Pomalidomide—PTGS2—bone marrow—breast cancer	0.000232	0.0117	CbGeAlD
Pomalidomide—PTGS2—female gonad—breast cancer	0.000224	0.0113	CbGeAlD
Pomalidomide—CYP3A4—female reproductive system—breast cancer	0.000215	0.0108	CbGeAlD
Pomalidomide—PTGS2—endocrine gland—breast cancer	0.000208	0.0105	CbGeAlD
Pomalidomide—ABCB1—epithelium—breast cancer	0.000205	0.0103	CbGeAlD
Pomalidomide—Thalidomide—TNF—breast cancer	0.000201	0.0333	CrCbGaD
Pomalidomide—ABCB1—endometrium—breast cancer	0.000184	0.00925	CbGeAlD
Pomalidomide—CYP3A4—endocrine gland—breast cancer	0.000182	0.00916	CbGeAlD
Pomalidomide—ABCB1—uterus—breast cancer	0.000169	0.00852	CbGeAlD
Pomalidomide—Thalidomide—PTGS1—breast cancer	0.000167	0.0277	CrCbGaD
Pomalidomide—ABCB1—pituitary gland—breast cancer	0.000166	0.00837	CbGeAlD
Pomalidomide—ABCB1—adipose tissue—breast cancer	0.000166	0.00834	CbGeAlD
Pomalidomide—Lenalidomide—PTGS2—breast cancer	0.000159	0.0264	CrCbGaD
Pomalidomide—Thalidomide—CYP1A1—breast cancer	0.000153	0.0253	CrCbGaD
Pomalidomide—ABCB1—female reproductive system—breast cancer	0.000152	0.00766	CbGeAlD
Pomalidomide—ABCB1—adrenal gland—breast cancer	0.000149	0.00748	CbGeAlD
Pomalidomide—PTGS2—lymph node—breast cancer	0.000144	0.00725	CbGeAlD
Pomalidomide—ABCB1—bone marrow—breast cancer	0.000144	0.00723	CbGeAlD
Pomalidomide—ABCB1—female gonad—breast cancer	0.000139	0.00697	CbGeAlD
Pomalidomide—Lenalidomide—ABCB1—breast cancer	0.000135	0.0225	CrCbGaD
Pomalidomide—ABCB1—endocrine gland—breast cancer	0.000129	0.00648	CbGeAlD
Pomalidomide—Thalidomide—PTGS2—breast cancer	9.54e-05	0.0158	CrCbGaD
Pomalidomide—ABCB1—lymph node—breast cancer	8.9e-05	0.00448	CbGeAlD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	3.91e-05	0.000228	CcSEcCtD
Pomalidomide—Cough—Capecitabine—breast cancer	3.91e-05	0.000228	CcSEcCtD
Pomalidomide—Urinary tract infection—Epirubicin—breast cancer	3.88e-05	0.000227	CcSEcCtD
Pomalidomide—Neutropenia—Doxorubicin—breast cancer	3.88e-05	0.000226	CcSEcCtD
Pomalidomide—Decreased appetite—Paclitaxel—breast cancer	3.88e-05	0.000226	CcSEcCtD
Pomalidomide—Hypersensitivity—Fluorouracil—breast cancer	3.86e-05	0.000225	CcSEcCtD
Pomalidomide—Upper respiratory tract infection—Doxorubicin—breast cancer	3.85e-05	0.000225	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Paclitaxel—breast cancer	3.85e-05	0.000225	CcSEcCtD
Pomalidomide—Fatigue—Paclitaxel—breast cancer	3.84e-05	0.000224	CcSEcCtD
Pomalidomide—Asthenia—Gemcitabine—breast cancer	3.82e-05	0.000223	CcSEcCtD
Pomalidomide—Arthralgia—Capecitabine—breast cancer	3.82e-05	0.000223	CcSEcCtD
Pomalidomide—Constipation—Paclitaxel—breast cancer	3.81e-05	0.000223	CcSEcCtD
Pomalidomide—Pain—Paclitaxel—breast cancer	3.81e-05	0.000223	CcSEcCtD
Pomalidomide—Confusional state—Docetaxel—breast cancer	3.81e-05	0.000222	CcSEcCtD
Pomalidomide—Anxiety—Capecitabine—breast cancer	3.8e-05	0.000222	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	3.79e-05	0.000221	CcSEcCtD
Pomalidomide—Urinary tract disorder—Methotrexate—breast cancer	3.79e-05	0.000221	CcSEcCtD
Pomalidomide—Hepatobiliary disease—Epirubicin—breast cancer	3.78e-05	0.000221	CcSEcCtD
Pomalidomide—Weight increased—Doxorubicin—breast cancer	3.77e-05	0.00022	CcSEcCtD
Pomalidomide—Epistaxis—Epirubicin—breast cancer	3.77e-05	0.00022	CcSEcCtD
Pomalidomide—Pruritus—Gemcitabine—breast cancer	3.77e-05	0.00022	CcSEcCtD
Pomalidomide—Nausea—Thiotepa—breast cancer	3.76e-05	0.000219	CcSEcCtD
Pomalidomide—Urethral disorder—Methotrexate—breast cancer	3.76e-05	0.000219	CcSEcCtD
Pomalidomide—Infection—Docetaxel—breast cancer	3.75e-05	0.000219	CcSEcCtD
Pomalidomide—Weight decreased—Doxorubicin—breast cancer	3.75e-05	0.000219	CcSEcCtD
Pomalidomide—Hyperglycaemia—Doxorubicin—breast cancer	3.74e-05	0.000218	CcSEcCtD
Pomalidomide—Diarrhoea—Mitoxantrone—breast cancer	3.74e-05	0.000218	CcSEcCtD
Pomalidomide—Diarrhoea—Irinotecan—breast cancer	3.74e-05	0.000218	CcSEcCtD
Pomalidomide—Pneumonia—Doxorubicin—breast cancer	3.72e-05	0.000217	CcSEcCtD
Pomalidomide—Nervous system disorder—Docetaxel—breast cancer	3.71e-05	0.000216	CcSEcCtD
Pomalidomide—Pruritus—Fluorouracil—breast cancer	3.7e-05	0.000216	CcSEcCtD
Pomalidomide—Thrombocytopenia—Docetaxel—breast cancer	3.7e-05	0.000216	CcSEcCtD
Pomalidomide—Infestation NOS—Doxorubicin—breast cancer	3.7e-05	0.000216	CcSEcCtD
Pomalidomide—Infestation—Doxorubicin—breast cancer	3.7e-05	0.000216	CcSEcCtD
Pomalidomide—Confusional state—Capecitabine—breast cancer	3.69e-05	0.000215	CcSEcCtD
Pomalidomide—Feeling abnormal—Paclitaxel—breast cancer	3.67e-05	0.000214	CcSEcCtD
Pomalidomide—Skin disorder—Docetaxel—breast cancer	3.67e-05	0.000214	CcSEcCtD
Pomalidomide—Diarrhoea—Gemcitabine—breast cancer	3.64e-05	0.000213	CcSEcCtD
Pomalidomide—Renal failure—Doxorubicin—breast cancer	3.63e-05	0.000212	CcSEcCtD
Pomalidomide—Infection—Capecitabine—breast cancer	3.63e-05	0.000212	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Doxorubicin—breast cancer	3.62e-05	0.000212	CcSEcCtD
Pomalidomide—Dizziness—Irinotecan—breast cancer	3.61e-05	0.000211	CcSEcCtD
Pomalidomide—Urinary tract infection—Doxorubicin—breast cancer	3.59e-05	0.00021	CcSEcCtD
Pomalidomide—Nervous system disorder—Capecitabine—breast cancer	3.59e-05	0.000209	CcSEcCtD
Pomalidomide—Diarrhoea—Fluorouracil—breast cancer	3.58e-05	0.000209	CcSEcCtD
Pomalidomide—Thrombocytopenia—Capecitabine—breast cancer	3.58e-05	0.000209	CcSEcCtD
Pomalidomide—Cardiac disorder—Methotrexate—breast cancer	3.56e-05	0.000208	CcSEcCtD
Pomalidomide—Skin disorder—Capecitabine—breast cancer	3.55e-05	0.000207	CcSEcCtD
Pomalidomide—Urinary tract disorder—Epirubicin—breast cancer	3.54e-05	0.000207	CcSEcCtD
Pomalidomide—Hyperhidrosis—Capecitabine—breast cancer	3.54e-05	0.000206	CcSEcCtD
Pomalidomide—Oedema peripheral—Epirubicin—breast cancer	3.53e-05	0.000206	CcSEcCtD
Pomalidomide—Connective tissue disorder—Epirubicin—breast cancer	3.53e-05	0.000206	CcSEcCtD
Pomalidomide—Body temperature increased—Paclitaxel—breast cancer	3.52e-05	0.000206	CcSEcCtD
Pomalidomide—Urethral disorder—Epirubicin—breast cancer	3.52e-05	0.000205	CcSEcCtD
Pomalidomide—Hepatobiliary disease—Doxorubicin—breast cancer	3.5e-05	0.000204	CcSEcCtD
Pomalidomide—Epistaxis—Doxorubicin—breast cancer	3.49e-05	0.000204	CcSEcCtD
Pomalidomide—Angiopathy—Methotrexate—breast cancer	3.48e-05	0.000203	CcSEcCtD
Pomalidomide—Vomiting—Mitoxantrone—breast cancer	3.48e-05	0.000203	CcSEcCtD
Pomalidomide—Vomiting—Irinotecan—breast cancer	3.48e-05	0.000203	CcSEcCtD
Pomalidomide—Dizziness—Fluorouracil—breast cancer	3.46e-05	0.000202	CcSEcCtD
Pomalidomide—Mediastinal disorder—Methotrexate—breast cancer	3.45e-05	0.000202	CcSEcCtD
Pomalidomide—Rash—Mitoxantrone—breast cancer	3.45e-05	0.000201	CcSEcCtD
Pomalidomide—Rash—Irinotecan—breast cancer	3.45e-05	0.000201	CcSEcCtD
Pomalidomide—Dermatitis—Mitoxantrone—breast cancer	3.44e-05	0.000201	CcSEcCtD
Pomalidomide—Dermatitis—Irinotecan—breast cancer	3.44e-05	0.000201	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Docetaxel—breast cancer	3.44e-05	0.000201	CcSEcCtD
Pomalidomide—Chills—Methotrexate—breast cancer	3.44e-05	0.000201	CcSEcCtD
Pomalidomide—Headache—Irinotecan—breast cancer	3.42e-05	0.0002	CcSEcCtD
Pomalidomide—Headache—Mitoxantrone—breast cancer	3.42e-05	0.0002	CcSEcCtD
Pomalidomide—Insomnia—Docetaxel—breast cancer	3.42e-05	0.000199	CcSEcCtD
Pomalidomide—Vomiting—Gemcitabine—breast cancer	3.39e-05	0.000198	CcSEcCtD
Pomalidomide—Dyspnoea—Docetaxel—breast cancer	3.37e-05	0.000197	CcSEcCtD
Pomalidomide—Mental disorder—Methotrexate—breast cancer	3.36e-05	0.000196	CcSEcCtD
Pomalidomide—Rash—Gemcitabine—breast cancer	3.36e-05	0.000196	CcSEcCtD
Pomalidomide—Dermatitis—Gemcitabine—breast cancer	3.35e-05	0.000196	CcSEcCtD
Pomalidomide—Malnutrition—Methotrexate—breast cancer	3.34e-05	0.000195	CcSEcCtD
Pomalidomide—Headache—Gemcitabine—breast cancer	3.34e-05	0.000195	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Capecitabine—breast cancer	3.33e-05	0.000195	CcSEcCtD
Pomalidomide—Cardiac disorder—Epirubicin—breast cancer	3.33e-05	0.000194	CcSEcCtD
Pomalidomide—Vomiting—Fluorouracil—breast cancer	3.33e-05	0.000194	CcSEcCtD
Pomalidomide—Insomnia—Capecitabine—breast cancer	3.31e-05	0.000193	CcSEcCtD
Pomalidomide—Rash—Fluorouracil—breast cancer	3.3e-05	0.000193	CcSEcCtD
Pomalidomide—Dermatitis—Fluorouracil—breast cancer	3.3e-05	0.000192	CcSEcCtD
Pomalidomide—Decreased appetite—Docetaxel—breast cancer	3.28e-05	0.000192	CcSEcCtD
Pomalidomide—Hypersensitivity—Paclitaxel—breast cancer	3.28e-05	0.000192	CcSEcCtD
Pomalidomide—Headache—Fluorouracil—breast cancer	3.28e-05	0.000191	CcSEcCtD
Pomalidomide—Urinary tract disorder—Doxorubicin—breast cancer	3.28e-05	0.000191	CcSEcCtD
Pomalidomide—Oedema peripheral—Doxorubicin—breast cancer	3.27e-05	0.000191	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Docetaxel—breast cancer	3.26e-05	0.00019	CcSEcCtD
Pomalidomide—Connective tissue disorder—Doxorubicin—breast cancer	3.26e-05	0.00019	CcSEcCtD
Pomalidomide—Dyspnoea—Capecitabine—breast cancer	3.26e-05	0.00019	CcSEcCtD
Pomalidomide—Fatigue—Docetaxel—breast cancer	3.26e-05	0.00019	CcSEcCtD
Pomalidomide—Angiopathy—Epirubicin—breast cancer	3.25e-05	0.00019	CcSEcCtD
Pomalidomide—Urethral disorder—Doxorubicin—breast cancer	3.25e-05	0.00019	CcSEcCtD
Pomalidomide—Nausea—Mitoxantrone—breast cancer	3.25e-05	0.00019	CcSEcCtD
Pomalidomide—Nausea—Irinotecan—breast cancer	3.25e-05	0.00019	CcSEcCtD
Pomalidomide—Mediastinal disorder—Epirubicin—breast cancer	3.23e-05	0.000189	CcSEcCtD
Pomalidomide—Pain—Docetaxel—breast cancer	3.23e-05	0.000189	CcSEcCtD
Pomalidomide—Constipation—Docetaxel—breast cancer	3.23e-05	0.000189	CcSEcCtD
Pomalidomide—Back pain—Methotrexate—breast cancer	3.23e-05	0.000188	CcSEcCtD
Pomalidomide—Chills—Epirubicin—breast cancer	3.22e-05	0.000188	CcSEcCtD
Pomalidomide—Asthenia—Paclitaxel—breast cancer	3.2e-05	0.000187	CcSEcCtD
Pomalidomide—Decreased appetite—Capecitabine—breast cancer	3.18e-05	0.000186	CcSEcCtD
Pomalidomide—Nausea—Gemcitabine—breast cancer	3.16e-05	0.000185	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Capecitabine—breast cancer	3.16e-05	0.000184	CcSEcCtD
Pomalidomide—Fatigue—Capecitabine—breast cancer	3.15e-05	0.000184	CcSEcCtD
Pomalidomide—Pruritus—Paclitaxel—breast cancer	3.15e-05	0.000184	CcSEcCtD
Pomalidomide—Mental disorder—Epirubicin—breast cancer	3.14e-05	0.000183	CcSEcCtD
Pomalidomide—Constipation—Capecitabine—breast cancer	3.13e-05	0.000183	CcSEcCtD
Pomalidomide—Pain—Capecitabine—breast cancer	3.13e-05	0.000183	CcSEcCtD
Pomalidomide—Malnutrition—Epirubicin—breast cancer	3.12e-05	0.000182	CcSEcCtD
Pomalidomide—Feeling abnormal—Docetaxel—breast cancer	3.11e-05	0.000182	CcSEcCtD
Pomalidomide—Nausea—Fluorouracil—breast cancer	3.11e-05	0.000182	CcSEcCtD
Pomalidomide—Anaemia—Methotrexate—breast cancer	3.08e-05	0.00018	CcSEcCtD
Pomalidomide—Cardiac disorder—Doxorubicin—breast cancer	3.08e-05	0.00018	CcSEcCtD
Pomalidomide—Diarrhoea—Paclitaxel—breast cancer	3.05e-05	0.000178	CcSEcCtD
Pomalidomide—Back pain—Epirubicin—breast cancer	3.02e-05	0.000176	CcSEcCtD
Pomalidomide—Feeling abnormal—Capecitabine—breast cancer	3.01e-05	0.000176	CcSEcCtD
Pomalidomide—Angiopathy—Doxorubicin—breast cancer	3.01e-05	0.000176	CcSEcCtD
Pomalidomide—Muscle spasms—Epirubicin—breast cancer	3e-05	0.000175	CcSEcCtD
Pomalidomide—Vertigo—Methotrexate—breast cancer	3e-05	0.000175	CcSEcCtD
Pomalidomide—Mediastinal disorder—Doxorubicin—breast cancer	2.99e-05	0.000175	CcSEcCtD
Pomalidomide—Body temperature increased—Docetaxel—breast cancer	2.99e-05	0.000174	CcSEcCtD
Pomalidomide—Leukopenia—Methotrexate—breast cancer	2.99e-05	0.000174	CcSEcCtD
Pomalidomide—Chills—Doxorubicin—breast cancer	2.98e-05	0.000174	CcSEcCtD
Pomalidomide—Dizziness—Paclitaxel—breast cancer	2.95e-05	0.000172	CcSEcCtD
Pomalidomide—Cough—Methotrexate—breast cancer	2.91e-05	0.00017	CcSEcCtD
Pomalidomide—Mental disorder—Doxorubicin—breast cancer	2.91e-05	0.00017	CcSEcCtD
Pomalidomide—Body temperature increased—Capecitabine—breast cancer	2.89e-05	0.000169	CcSEcCtD
Pomalidomide—Malnutrition—Doxorubicin—breast cancer	2.89e-05	0.000169	CcSEcCtD
Pomalidomide—Anaemia—Epirubicin—breast cancer	2.89e-05	0.000168	CcSEcCtD
Pomalidomide—Arthralgia—Methotrexate—breast cancer	2.84e-05	0.000166	CcSEcCtD
Pomalidomide—Vomiting—Paclitaxel—breast cancer	2.83e-05	0.000165	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.82e-05	0.000165	CcSEcCtD
Pomalidomide—Rash—Paclitaxel—breast cancer	2.81e-05	0.000164	CcSEcCtD
Pomalidomide—Dermatitis—Paclitaxel—breast cancer	2.81e-05	0.000164	CcSEcCtD
Pomalidomide—Vertigo—Epirubicin—breast cancer	2.81e-05	0.000164	CcSEcCtD
Pomalidomide—Leukopenia—Epirubicin—breast cancer	2.8e-05	0.000163	CcSEcCtD
Pomalidomide—Back pain—Doxorubicin—breast cancer	2.8e-05	0.000163	CcSEcCtD
Pomalidomide—Headache—Paclitaxel—breast cancer	2.79e-05	0.000163	CcSEcCtD
Pomalidomide—Hypersensitivity—Docetaxel—breast cancer	2.78e-05	0.000162	CcSEcCtD
Pomalidomide—Muscle spasms—Doxorubicin—breast cancer	2.78e-05	0.000162	CcSEcCtD
Pomalidomide—Confusional state—Methotrexate—breast cancer	2.75e-05	0.00016	CcSEcCtD
Pomalidomide—Cough—Epirubicin—breast cancer	2.73e-05	0.000159	CcSEcCtD
Pomalidomide—Asthenia—Docetaxel—breast cancer	2.71e-05	0.000158	CcSEcCtD
Pomalidomide—Infection—Methotrexate—breast cancer	2.71e-05	0.000158	CcSEcCtD
Pomalidomide—Hypersensitivity—Capecitabine—breast cancer	2.7e-05	0.000157	CcSEcCtD
Pomalidomide—Pruritus—Docetaxel—breast cancer	2.67e-05	0.000156	CcSEcCtD
Pomalidomide—Nervous system disorder—Methotrexate—breast cancer	2.67e-05	0.000156	CcSEcCtD
Pomalidomide—Anaemia—Doxorubicin—breast cancer	2.67e-05	0.000156	CcSEcCtD
Pomalidomide—Thrombocytopenia—Methotrexate—breast cancer	2.67e-05	0.000156	CcSEcCtD
Pomalidomide—Arthralgia—Epirubicin—breast cancer	2.66e-05	0.000155	CcSEcCtD
Pomalidomide—Anxiety—Epirubicin—breast cancer	2.65e-05	0.000155	CcSEcCtD
Pomalidomide—Nausea—Paclitaxel—breast cancer	2.65e-05	0.000155	CcSEcCtD
Pomalidomide—Skin disorder—Methotrexate—breast cancer	2.65e-05	0.000154	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.64e-05	0.000154	CcSEcCtD
Pomalidomide—Hyperhidrosis—Methotrexate—breast cancer	2.63e-05	0.000154	CcSEcCtD
Pomalidomide—Asthenia—Capecitabine—breast cancer	2.62e-05	0.000153	CcSEcCtD
Pomalidomide—Vertigo—Doxorubicin—breast cancer	2.6e-05	0.000152	CcSEcCtD
Pomalidomide—Pruritus—Capecitabine—breast cancer	2.59e-05	0.000151	CcSEcCtD
Pomalidomide—Leukopenia—Doxorubicin—breast cancer	2.59e-05	0.000151	CcSEcCtD
Pomalidomide—Diarrhoea—Docetaxel—breast cancer	2.59e-05	0.000151	CcSEcCtD
Pomalidomide—Confusional state—Epirubicin—breast cancer	2.57e-05	0.00015	CcSEcCtD
Pomalidomide—Infection—Epirubicin—breast cancer	2.53e-05	0.000148	CcSEcCtD
Pomalidomide—Cough—Doxorubicin—breast cancer	2.52e-05	0.000147	CcSEcCtD
Pomalidomide—Diarrhoea—Capecitabine—breast cancer	2.5e-05	0.000146	CcSEcCtD
Pomalidomide—Nervous system disorder—Epirubicin—breast cancer	2.5e-05	0.000146	CcSEcCtD
Pomalidomide—Dizziness—Docetaxel—breast cancer	2.5e-05	0.000146	CcSEcCtD
Pomalidomide—Thrombocytopenia—Epirubicin—breast cancer	2.5e-05	0.000146	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Methotrexate—breast cancer	2.48e-05	0.000145	CcSEcCtD
Pomalidomide—Skin disorder—Epirubicin—breast cancer	2.48e-05	0.000144	CcSEcCtD
Pomalidomide—Hyperhidrosis—Epirubicin—breast cancer	2.46e-05	0.000144	CcSEcCtD
Pomalidomide—Insomnia—Methotrexate—breast cancer	2.46e-05	0.000144	CcSEcCtD
Pomalidomide—Arthralgia—Doxorubicin—breast cancer	2.46e-05	0.000144	CcSEcCtD
Pomalidomide—Anxiety—Doxorubicin—breast cancer	2.45e-05	0.000143	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.44e-05	0.000143	CcSEcCtD
Pomalidomide—Dyspnoea—Methotrexate—breast cancer	2.43e-05	0.000142	CcSEcCtD
Pomalidomide—Dizziness—Capecitabine—breast cancer	2.42e-05	0.000141	CcSEcCtD
Pomalidomide—Vomiting—Docetaxel—breast cancer	2.4e-05	0.00014	CcSEcCtD
Pomalidomide—Rash—Docetaxel—breast cancer	2.38e-05	0.000139	CcSEcCtD
Pomalidomide—Dermatitis—Docetaxel—breast cancer	2.38e-05	0.000139	CcSEcCtD
Pomalidomide—Confusional state—Doxorubicin—breast cancer	2.38e-05	0.000139	CcSEcCtD
Pomalidomide—Decreased appetite—Methotrexate—breast cancer	2.37e-05	0.000138	CcSEcCtD
Pomalidomide—Headache—Docetaxel—breast cancer	2.37e-05	0.000138	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Methotrexate—breast cancer	2.35e-05	0.000137	CcSEcCtD
Pomalidomide—Fatigue—Methotrexate—breast cancer	2.35e-05	0.000137	CcSEcCtD
Pomalidomide—Infection—Doxorubicin—breast cancer	2.34e-05	0.000137	CcSEcCtD
Pomalidomide—Pain—Methotrexate—breast cancer	2.33e-05	0.000136	CcSEcCtD
Pomalidomide—Vomiting—Capecitabine—breast cancer	2.33e-05	0.000136	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Epirubicin—breast cancer	2.32e-05	0.000136	CcSEcCtD
Pomalidomide—Nervous system disorder—Doxorubicin—breast cancer	2.31e-05	0.000135	CcSEcCtD
Pomalidomide—Thrombocytopenia—Doxorubicin—breast cancer	2.31e-05	0.000135	CcSEcCtD
Pomalidomide—Rash—Capecitabine—breast cancer	2.31e-05	0.000135	CcSEcCtD
Pomalidomide—Insomnia—Epirubicin—breast cancer	2.31e-05	0.000135	CcSEcCtD
Pomalidomide—Dermatitis—Capecitabine—breast cancer	2.3e-05	0.000135	CcSEcCtD
Pomalidomide—Headache—Capecitabine—breast cancer	2.29e-05	0.000134	CcSEcCtD
Pomalidomide—Skin disorder—Doxorubicin—breast cancer	2.29e-05	0.000134	CcSEcCtD
Pomalidomide—Hyperhidrosis—Doxorubicin—breast cancer	2.28e-05	0.000133	CcSEcCtD
Pomalidomide—Dyspnoea—Epirubicin—breast cancer	2.27e-05	0.000133	CcSEcCtD
Pomalidomide—Nausea—Docetaxel—breast cancer	2.24e-05	0.000131	CcSEcCtD
Pomalidomide—Feeling abnormal—Methotrexate—breast cancer	2.24e-05	0.000131	CcSEcCtD
Pomalidomide—Decreased appetite—Epirubicin—breast cancer	2.22e-05	0.000129	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Epirubicin—breast cancer	2.2e-05	0.000128	CcSEcCtD
Pomalidomide—Fatigue—Epirubicin—breast cancer	2.2e-05	0.000128	CcSEcCtD
Pomalidomide—Pain—Epirubicin—breast cancer	2.18e-05	0.000127	CcSEcCtD
Pomalidomide—Constipation—Epirubicin—breast cancer	2.18e-05	0.000127	CcSEcCtD
Pomalidomide—Nausea—Capecitabine—breast cancer	2.17e-05	0.000127	CcSEcCtD
Pomalidomide—Body temperature increased—Methotrexate—breast cancer	2.15e-05	0.000126	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.15e-05	0.000125	CcSEcCtD
Pomalidomide—Insomnia—Doxorubicin—breast cancer	2.13e-05	0.000124	CcSEcCtD
Pomalidomide—Dyspnoea—Doxorubicin—breast cancer	2.1e-05	0.000123	CcSEcCtD
Pomalidomide—Feeling abnormal—Epirubicin—breast cancer	2.1e-05	0.000123	CcSEcCtD
Pomalidomide—Decreased appetite—Doxorubicin—breast cancer	2.05e-05	0.00012	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Doxorubicin—breast cancer	2.04e-05	0.000119	CcSEcCtD
Pomalidomide—Fatigue—Doxorubicin—breast cancer	2.03e-05	0.000119	CcSEcCtD
Pomalidomide—Pain—Doxorubicin—breast cancer	2.02e-05	0.000118	CcSEcCtD
Pomalidomide—Constipation—Doxorubicin—breast cancer	2.02e-05	0.000118	CcSEcCtD
Pomalidomide—Body temperature increased—Epirubicin—breast cancer	2.01e-05	0.000118	CcSEcCtD
Pomalidomide—Hypersensitivity—Methotrexate—breast cancer	2.01e-05	0.000117	CcSEcCtD
Pomalidomide—Asthenia—Methotrexate—breast cancer	1.95e-05	0.000114	CcSEcCtD
Pomalidomide—Feeling abnormal—Doxorubicin—breast cancer	1.94e-05	0.000113	CcSEcCtD
Pomalidomide—Pruritus—Methotrexate—breast cancer	1.93e-05	0.000112	CcSEcCtD
Pomalidomide—Hypersensitivity—Epirubicin—breast cancer	1.88e-05	0.00011	CcSEcCtD
Pomalidomide—Body temperature increased—Doxorubicin—breast cancer	1.86e-05	0.000109	CcSEcCtD
Pomalidomide—Diarrhoea—Methotrexate—breast cancer	1.86e-05	0.000109	CcSEcCtD
Pomalidomide—Asthenia—Epirubicin—breast cancer	1.83e-05	0.000107	CcSEcCtD
Pomalidomide—Pruritus—Epirubicin—breast cancer	1.8e-05	0.000105	CcSEcCtD
Pomalidomide—Dizziness—Methotrexate—breast cancer	1.8e-05	0.000105	CcSEcCtD
Pomalidomide—Diarrhoea—Epirubicin—breast cancer	1.74e-05	0.000102	CcSEcCtD
Pomalidomide—Hypersensitivity—Doxorubicin—breast cancer	1.74e-05	0.000101	CcSEcCtD
Pomalidomide—Vomiting—Methotrexate—breast cancer	1.73e-05	0.000101	CcSEcCtD
Pomalidomide—Rash—Methotrexate—breast cancer	1.72e-05	0.0001	CcSEcCtD
Pomalidomide—Dermatitis—Methotrexate—breast cancer	1.72e-05	0.0001	CcSEcCtD
Pomalidomide—Headache—Methotrexate—breast cancer	1.71e-05	9.96e-05	CcSEcCtD
Pomalidomide—Asthenia—Doxorubicin—breast cancer	1.69e-05	9.88e-05	CcSEcCtD
Pomalidomide—Dizziness—Epirubicin—breast cancer	1.69e-05	9.84e-05	CcSEcCtD
Pomalidomide—Pruritus—Doxorubicin—breast cancer	1.67e-05	9.74e-05	CcSEcCtD
Pomalidomide—Vomiting—Epirubicin—breast cancer	1.62e-05	9.46e-05	CcSEcCtD
Pomalidomide—Nausea—Methotrexate—breast cancer	1.62e-05	9.44e-05	CcSEcCtD
Pomalidomide—Diarrhoea—Doxorubicin—breast cancer	1.61e-05	9.42e-05	CcSEcCtD
Pomalidomide—Rash—Epirubicin—breast cancer	1.61e-05	9.38e-05	CcSEcCtD
Pomalidomide—Dermatitis—Epirubicin—breast cancer	1.61e-05	9.37e-05	CcSEcCtD
Pomalidomide—Headache—Epirubicin—breast cancer	1.6e-05	9.32e-05	CcSEcCtD
Pomalidomide—Dizziness—Doxorubicin—breast cancer	1.56e-05	9.1e-05	CcSEcCtD
Pomalidomide—Nausea—Epirubicin—breast cancer	1.51e-05	8.84e-05	CcSEcCtD
Pomalidomide—Vomiting—Doxorubicin—breast cancer	1.5e-05	8.75e-05	CcSEcCtD
Pomalidomide—Rash—Doxorubicin—breast cancer	1.49e-05	8.68e-05	CcSEcCtD
Pomalidomide—Dermatitis—Doxorubicin—breast cancer	1.49e-05	8.67e-05	CcSEcCtD
Pomalidomide—Headache—Doxorubicin—breast cancer	1.48e-05	8.62e-05	CcSEcCtD
Pomalidomide—Nausea—Doxorubicin—breast cancer	1.4e-05	8.18e-05	CcSEcCtD
Pomalidomide—PTGS2—Metabolism—STK11—breast cancer	4.47e-06	4.69e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NRG1—breast cancer	4.46e-06	4.67e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CPT1A—breast cancer	4.45e-06	4.66e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MTR—breast cancer	4.45e-06	4.66e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ABCG2—breast cancer	4.45e-06	4.66e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALDH1A1—breast cancer	4.44e-06	4.65e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALDH7A1—breast cancer	4.44e-06	4.65e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—H2AFX—breast cancer	4.43e-06	4.64e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—IDH1—breast cancer	4.41e-06	4.62e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTA1—breast cancer	4.41e-06	4.62e-05	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—AKT1—breast cancer	4.38e-06	4.59e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HPGDS—breast cancer	4.36e-06	4.57e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NAT2—breast cancer	4.36e-06	4.57e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HBA1—breast cancer	4.34e-06	4.54e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ERCC2—breast cancer	4.27e-06	4.47e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—FHL2—breast cancer	4.25e-06	4.46e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADSL—breast cancer	4.25e-06	4.46e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PHGDH—breast cancer	4.25e-06	4.46e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—UMPS—breast cancer	4.25e-06	4.46e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NME1—breast cancer	4.25e-06	4.46e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ACHE—breast cancer	4.23e-06	4.44e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTT1—breast cancer	4.23e-06	4.44e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.2e-06	4.4e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ERBB3—breast cancer	4.18e-06	4.38e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LDHB—breast cancer	4.17e-06	4.37e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—BRIP1—breast cancer	4.17e-06	4.37e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HPSE—breast cancer	4.17e-06	4.37e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—FGFR2—breast cancer	4.17e-06	4.37e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—COMT—breast cancer	4.16e-06	4.36e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTP1—breast cancer	4.14e-06	4.34e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	4.11e-06	4.3e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HMOX1—breast cancer	4.08e-06	4.28e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ITPR1—breast cancer	4.07e-06	4.27e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MTHFR—breast cancer	4.01e-06	4.21e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP17A1—breast cancer	4.01e-06	4.2e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TERT—breast cancer	4e-06	4.19e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ENO1—breast cancer	3.97e-06	4.16e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS1—breast cancer	3.97e-06	4.16e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCC1—breast cancer	3.96e-06	4.14e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HMMR—breast cancer	3.96e-06	4.14e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTA3—breast cancer	3.96e-06	4.14e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	3.94e-06	4.13e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ABCB1—breast cancer	3.92e-06	4.11e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP2D6—breast cancer	3.89e-06	4.08e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—FGFR1—breast cancer	3.89e-06	4.07e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—TYMS—breast cancer	3.85e-06	4.03e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARGC1B—breast cancer	3.83e-06	4.01e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HIF1A—breast cancer	3.83e-06	4.01e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DPYD—breast cancer	3.82e-06	4e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MED12—breast cancer	3.82e-06	4e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NCOA2—breast cancer	3.82e-06	4e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PLA2G4A—breast cancer	3.8e-06	3.99e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTM1—breast cancer	3.8e-06	3.99e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NCOR1—breast cancer	3.8e-06	3.99e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALDOA—breast cancer	3.76e-06	3.94e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	3.71e-06	3.89e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—FASN—breast cancer	3.7e-06	3.88e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CAV1—breast cancer	3.7e-06	3.88e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—BCHE—breast cancer	3.69e-06	3.86e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NCOA3—breast cancer	3.65e-06	3.83e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC5A5—breast cancer	3.64e-06	3.82e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GPX1—breast cancer	3.64e-06	3.82e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC2A2—breast cancer	3.63e-06	3.8e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CA9—breast cancer	3.62e-06	3.79e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTA4—breast cancer	3.62e-06	3.79e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP1A1—breast cancer	3.61e-06	3.78e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	3.59e-06	3.76e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ERCC2—breast cancer	3.58e-06	3.75e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CPT1A—breast cancer	3.55e-06	3.72e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MTR—breast cancer	3.55e-06	3.72e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCG2—breast cancer	3.55e-06	3.72e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTA2—breast cancer	3.53e-06	3.69e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GPX2—breast cancer	3.53e-06	3.69e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—SLC2A1—breast cancer	3.52e-06	3.69e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NQO1—breast cancer	3.52e-06	3.69e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HPGDS—breast cancer	3.48e-06	3.65e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GPX4—breast cancer	3.48e-06	3.65e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SULT1A1—breast cancer	3.48e-06	3.65e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS2—breast cancer	3.48e-06	3.65e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HBA1—breast cancer	3.46e-06	3.63e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOTCH1—breast cancer	3.45e-06	3.61e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP3A4—breast cancer	3.43e-06	3.59e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—IDH1—breast cancer	3.4e-06	3.56e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTA1—breast cancer	3.4e-06	3.56e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ACHE—breast cancer	3.38e-06	3.54e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTT1—breast cancer	3.38e-06	3.54e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP1B1—breast cancer	3.37e-06	3.53e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—KIT—breast cancer	3.37e-06	3.53e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APC—breast cancer	3.37e-06	3.53e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NAT2—breast cancer	3.36e-06	3.52e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MTHFR—breast cancer	3.36e-06	3.52e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	3.35e-06	3.52e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—EGF—breast cancer	3.33e-06	3.49e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HSP90AA1—breast cancer	3.31e-06	3.47e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NCOA1—breast cancer	3.22e-06	3.37e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP17A1—breast cancer	3.2e-06	3.35e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—STK11—breast cancer	3.17e-06	3.32e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP19A1—breast cancer	3.17e-06	3.32e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—BRAF—breast cancer	3.17e-06	3.32e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS1—breast cancer	3.17e-06	3.32e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ENO1—breast cancer	3.17e-06	3.32e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.15e-06	3.31e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.11e-06	3.26e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP2D6—breast cancer	3.1e-06	3.25e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CAV1—breast cancer	3.1e-06	3.25e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—AKT2—breast cancer	3.09e-06	3.23e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NCOA2—breast cancer	3.05e-06	3.19e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PIK3CD—breast cancer	2.96e-06	3.11e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.96e-06	3.1e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—FASN—breast cancer	2.96e-06	3.1e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MED12—breast cancer	2.95e-06	3.09e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DPYD—breast cancer	2.95e-06	3.09e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—COMT—breast cancer	2.95e-06	3.09e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—BCHE—breast cancer	2.94e-06	3.08e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTP1—breast cancer	2.93e-06	3.07e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SERPINE1—breast cancer	2.93e-06	3.07e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC5A5—breast cancer	2.91e-06	3.05e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALDOA—breast cancer	2.9e-06	3.04e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HMOX1—breast cancer	2.89e-06	3.03e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ITPR1—breast cancer	2.89e-06	3.03e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3CG—breast cancer	2.82e-06	2.96e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NCOA3—breast cancer	2.82e-06	2.95e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NQO1—breast cancer	2.81e-06	2.94e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—SLC2A1—breast cancer	2.81e-06	2.94e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS3—breast cancer	2.8e-06	2.93e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC2A2—breast cancer	2.8e-06	2.93e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.75e-06	2.88e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCG2—breast cancer	2.74e-06	2.87e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CPT1A—breast cancer	2.74e-06	2.87e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MTR—breast cancer	2.74e-06	2.87e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP3A4—breast cancer	2.74e-06	2.87e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—TYMS—breast cancer	2.73e-06	2.86e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.72e-06	2.86e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PLA2G4A—breast cancer	2.7e-06	2.83e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NCOR1—breast cancer	2.7e-06	2.83e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTM1—breast cancer	2.7e-06	2.83e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP1B1—breast cancer	2.69e-06	2.82e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HPGDS—breast cancer	2.69e-06	2.82e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HBA1—breast cancer	2.67e-06	2.8e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MDM2—breast cancer	2.66e-06	2.78e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—RAF1—breast cancer	2.65e-06	2.77e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HSP90AA1—breast cancer	2.64e-06	2.77e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ERBB2—breast cancer	2.62e-06	2.74e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTT1—breast cancer	2.61e-06	2.73e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ACHE—breast cancer	2.61e-06	2.73e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MTOR—breast cancer	2.58e-06	2.71e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PIK3CB—breast cancer	2.58e-06	2.71e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GPX1—breast cancer	2.58e-06	2.71e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CD4—breast cancer	2.58e-06	2.7e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NCOA1—breast cancer	2.57e-06	2.69e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP1A1—breast cancer	2.56e-06	2.68e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ERCC2—breast cancer	2.53e-06	2.66e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—STK11—breast cancer	2.53e-06	2.65e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP19A1—breast cancer	2.53e-06	2.65e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3CD—breast cancer	2.48e-06	2.6e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP17A1—breast cancer	2.47e-06	2.59e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALB—breast cancer	2.45e-06	2.57e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ENO1—breast cancer	2.44e-06	2.56e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS1—breast cancer	2.44e-06	2.56e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CDKN1B—breast cancer	2.42e-06	2.54e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP2D6—breast cancer	2.4e-06	2.51e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MTHFR—breast cancer	2.38e-06	2.5e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.38e-06	2.49e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—COMT—breast cancer	2.35e-06	2.47e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NCOA2—breast cancer	2.35e-06	2.46e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NOS3—breast cancer	2.34e-06	2.46e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTP1—breast cancer	2.34e-06	2.45e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HMOX1—breast cancer	2.31e-06	2.42e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ITPR1—breast cancer	2.3e-06	2.42e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CTNNB1—breast cancer	2.29e-06	2.4e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—FASN—breast cancer	2.28e-06	2.39e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—BCHE—breast cancer	2.27e-06	2.38e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC5A5—breast cancer	2.24e-06	2.35e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CDKN1A—breast cancer	2.24e-06	2.35e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PTEN—breast cancer	2.23e-06	2.34e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCB1—breast cancer	2.22e-06	2.32e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CAV1—breast cancer	2.2e-06	2.3e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—TYMS—breast cancer	2.18e-06	2.28e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—SLC2A1—breast cancer	2.17e-06	2.27e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NQO1—breast cancer	2.17e-06	2.27e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3CB—breast cancer	2.16e-06	2.27e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NCOR1—breast cancer	2.15e-06	2.26e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.15e-06	2.26e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTM1—breast cancer	2.15e-06	2.26e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP1B1—breast cancer	2.08e-06	2.18e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SRC—breast cancer	2.07e-06	2.17e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GPX1—breast cancer	2.06e-06	2.16e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP1A1—breast cancer	2.04e-06	2.14e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.04e-06	2.14e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ERCC2—breast cancer	2.02e-06	2.12e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3CG—breast cancer	2e-06	2.1e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—STAT3—breast cancer	2e-06	2.09e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NCOA1—breast cancer	1.98e-06	2.08e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—STK11—breast cancer	1.95e-06	2.05e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP19A1—breast cancer	1.95e-06	2.05e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MAPK3—breast cancer	1.91e-06	2e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MTHFR—breast cancer	1.9e-06	1.99e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PTEN—breast cancer	1.87e-06	1.96e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MYC—breast cancer	1.86e-06	1.94e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TGFB1—breast cancer	1.85e-06	1.94e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—COMT—breast cancer	1.82e-06	1.9e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—EGFR—breast cancer	1.81e-06	1.9e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTP1—breast cancer	1.81e-06	1.89e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HMOX1—breast cancer	1.78e-06	1.87e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ITPR1—breast cancer	1.78e-06	1.86e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3CD—breast cancer	1.76e-06	1.84e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CAV1—breast cancer	1.75e-06	1.84e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALB—breast cancer	1.74e-06	1.82e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—KRAS—breast cancer	1.71e-06	1.8e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCB1—breast cancer	1.71e-06	1.79e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—TYMS—breast cancer	1.68e-06	1.76e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.68e-06	1.76e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NOS3—breast cancer	1.66e-06	1.74e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.66e-06	1.74e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NCOR1—breast cancer	1.66e-06	1.74e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTM1—breast cancer	1.66e-06	1.74e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3CG—breast cancer	1.6e-06	1.67e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GPX1—breast cancer	1.59e-06	1.67e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PIK3CA—breast cancer	1.58e-06	1.65e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP1A1—breast cancer	1.57e-06	1.65e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ERCC2—breast cancer	1.56e-06	1.64e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3CB—breast cancer	1.53e-06	1.61e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS2—breast cancer	1.52e-06	1.59e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MTHFR—breast cancer	1.47e-06	1.54e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HRAS—breast cancer	1.46e-06	1.53e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3CD—breast cancer	1.4e-06	1.47e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6—breast cancer	1.39e-06	1.46e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALB—breast cancer	1.39e-06	1.45e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CAV1—breast cancer	1.35e-06	1.42e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NOS3—breast cancer	1.33e-06	1.39e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTEN—breast cancer	1.33e-06	1.39e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PIK3CA—breast cancer	1.32e-06	1.38e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—AKT1—breast cancer	1.29e-06	1.35e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3CG—breast cancer	1.23e-06	1.29e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3CB—breast cancer	1.22e-06	1.28e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS2—breast cancer	1.21e-06	1.27e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3CD—breast cancer	1.08e-06	1.14e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AKT1—breast cancer	1.08e-06	1.13e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALB—breast cancer	1.07e-06	1.12e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTEN—breast cancer	1.06e-06	1.11e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NOS3—breast cancer	1.02e-06	1.07e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3CB—breast cancer	9.45e-07	9.9e-06	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS2—breast cancer	9.36e-07	9.81e-06	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PIK3CA—breast cancer	9.35e-07	9.8e-06	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTEN—breast cancer	8.17e-07	8.56e-06	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AKT1—breast cancer	7.64e-07	8.01e-06	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PIK3CA—breast cancer	7.46e-07	7.82e-06	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AKT1—breast cancer	6.1e-07	6.39e-06	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PIK3CA—breast cancer	5.76e-07	6.04e-06	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AKT1—breast cancer	4.71e-07	4.93e-06	CbGpPWpGaD
